Location History:
- Woodside, CA (US) (1998 - 2012)
- Burlingame, CA (US) (2006 - 2012)
- Stanford, CA (US) (1988 - 2013)
- Menlo Park, CA (US) (2018)
Company Filing History:
Years Active: 1988-2018
Title: Innovations of Michele P. Calos
Introduction
Michele P. Calos is a prominent inventor based in Woodside, California, known for his significant contributions to the field of genetic engineering. With a total of 13 patents to his name, Calos has made remarkable advancements in the integration of transgenes into human cells. His work has the potential to revolutionize therapeutic approaches in medicine.
Latest Patents
One of Calos's latest patents focuses on the site-specific integration of transgenes into human cells. This invention provides methods for inserting a polynucleotide sequence into the genome of a human cell, specifically targeting the H11 locus. The methods result in the successful insertion of a polynucleotide sequence of interest, which is crucial for various genetic applications. Another notable patent involves a unidirectional, site-specific integration system that allows for the integration of nucleic acids into the genome of target cells. This system includes a mutant integrase and a targeting vector, facilitating precise genetic modifications.
Career Highlights
Throughout his career, Michele P. Calos has worked with esteemed institutions, including Leland Stanford Junior University and Poetic Genetics, LLC. His research has significantly contributed to the understanding and application of genetic engineering techniques. Calos's innovative approaches have garnered attention in the scientific community, establishing him as a leading figure in his field.
Collaborations
Calos has collaborated with notable colleagues, including Ruby Yanru Tsai and Fangfang Zhu. These partnerships have further enhanced his research and development efforts, leading to groundbreaking advancements in genetic engineering.
Conclusion
Michele P. Calos's work exemplifies the intersection of innovation and science, particularly in the realm of genetic engineering. His patents and collaborations reflect a commitment to advancing medical technology and improving human health.